Mind Medicine Inc (STU:MMQ)
€ 6.875 0.17 (2.54%) Market Cap: 494.11 Mil Enterprise Value: 271.67 Mil PE Ratio: 0 PB Ratio: 2.67 GF Score: 38/100

Mind Medicine (MindMed) Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 28, 2023 / 05:15PM GMT
Release Date Price: €3.18 (-11.19%)
Charles Duncan
Cantor Fitzgerald - Analyst

So I promise this session will be quite interesting. This is a panel and it really should be two separate sessions because there's a lot to talk about for these two companies. So this is a panel that is meant to -- I'll call it -- illustrate emerging and I think quite interesting therapeutic candidates to treat mental health disorders.

So these are two companies that are emerging that will have data by the end of this year that will enable a path forward, perhaps even registrational studies. So that's why we're having this panel. They are two companies that I actually cover. Cybin is a company that has a couple of candidates that will read out by the end of this year.

And with us today is Doug Drysdale, the company's CEO; as well as George Tziras, the CEO of a company called Small Pharma. And the reason they're together is because they're merging and expanding their pipeline. And then the other company's called MindMed, and we have the pleasure -- I have the pleasure -- of introducing Dr. Dan Karlin, the company's Chief Medical Officer, and he

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot